Kindred Biosciences
(KIN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 46,715 | 12,911 | 11,620 | 16,614 | 26,898 |
| Marketable Securities | 27,484 | 50,240 | 46,758 | 45,723 | 40,218 |
| Receivables | 1,555 | 12,715 | 624 | 739 | 263 |
| Inventories | 0 | 0 | 207 | 386 | 389 |
| TOTAL | $79,083 | $79,091 | $62,624 | $67,756 | $72,771 |
| Non-Current Assets | |||||
| PPE Net | 26,555 | 27,451 | 28,204 | 28,593 | 29,569 |
| Investments And Advances | 159 | 158 | 1,500 | 4,500 | 10,457 |
| Other Non-Current Assets | 3,075 | 3,279 | 3,486 | 3,690 | 3,145 |
| TOTAL | $29,789 | $30,888 | $33,190 | $36,783 | $43,171 |
| Total Assets | $108,872 | $109,979 | $95,814 | $104,539 | $115,942 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,519 | 2,815 | 1,111 | N/A | N/A |
| Accounts payable and accrued liabilities | 926 | 353 | 145 | 347 | 639 |
| Accrued Expenses | 4,951 | 2,540 | 4,815 | 4,173 | 5,653 |
| TOTAL | $11,260 | $6,552 | $6,896 | $5,331 | $6,949 |
| Non-Current Liabilities | |||||
| Long Term Debt | 15,351 | 16,926 | 18,502 | 19,524 | 19,436 |
| Other Non-Current Liabilities | 2,492 | 2,716 | 2,934 | 3,147 | 2,741 |
| TOTAL | $17,843 | $19,642 | $21,436 | $22,671 | $22,177 |
| Total Liabilities | $29,103 | $26,194 | $28,332 | $28,002 | $29,126 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 45,462 | 45,274 | 41,449 | 39,449 | 39,368 |
| Common Shares | 5 | 4 | 4 | 4 | 4 |
| Retained earnings | -263,723 | -254,595 | -244,855 | -233,957 | -221,774 |
| Other shareholders' equity | -1 | 2 | 12 | 24 | 44 |
| TOTAL | $79,769 | $83,785 | $67,482 | $76,537 | $86,816 |
| Total Liabilities And Equity | $108,872 | $109,979 | $95,814 | $104,539 | $115,942 |